These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29379558)

  • 21. Systematic genetic analysis of pediatric patients with autoinflammatory diseases.
    Poker Y; von Hardenberg S; Hofmann W; Tang M; Baumann U; Schwerk N; Wetzke M; Lindenthal V; Auber B; Schlegelberger B; Ott H; von Bismarck P; Viemann D; Dressler F; Klemann C; Bergmann AK
    Front Genet; 2023; 14():1065907. PubMed ID: 36777733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.
    Sawyer SL; Hartley T; Dyment DA; Beaulieu CL; Schwartzentruber J; Smith A; Bedford HM; Bernard G; Bernier FP; Brais B; Bulman DE; Warman Chardon J; Chitayat D; Deladoëy J; Fernandez BA; Frosk P; Geraghty MT; Gerull B; Gibson W; Gow RM; Graham GE; Green JS; Heon E; Horvath G; Innes AM; Jabado N; Kim RH; Koenekoop RK; Khan A; Lehmann OJ; Mendoza-Londono R; Michaud JL; Nikkel SM; Penney LS; Polychronakos C; Richer J; Rouleau GA; Samuels ME; Siu VM; Suchowersky O; Tarnopolsky MA; Yoon G; Zahir FR; ; ; Majewski J; Boycott KM
    Clin Genet; 2016 Mar; 89(3):275-84. PubMed ID: 26283276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited metabolic disorders in adults: systematic review on patient characteristics and diagnostic yield of broad sequencing techniques (exome and genome sequencing).
    Ferreira EA; Buijs MJN; Wijngaard R; Daams JG; Datema MR; Engelen M; van Karnebeek CDM; Oud MM; Vaz FM; Wamelink MMC; van der Crabben SN; Langeveld M
    Front Neurol; 2023; 14():1206106. PubMed ID: 37560457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.
    Harris E; Topf A; Barresi R; Hudson J; Powell H; Tellez J; Hicks D; Porter A; Bertoli M; Evangelista T; Marini-Betollo C; Magnússon Ó; Lek M; MacArthur D; Bushby K; Lochmüller H; Straub V
    Orphanet J Rare Dis; 2017 Sep; 12(1):151. PubMed ID: 28877744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.
    Cherukuri PF; Maduro V; Fuentes-Fajardo KV; Lam K; ; Adams DR; Tifft CJ; Mullikin JC; Gahl WA; Boerkoel CF
    BMC Genomics; 2015 Nov; 16():998. PubMed ID: 26602380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of whole exome sequencing in unsolved patients with a clinical suspicion of a mitochondrial disorder in Estonia.
    Puusepp S; Reinson K; Pajusalu S; Murumets Ü; Õiglane-Shlik E; Rein R; Talvik I; Rodenburg RJ; Õunap K
    Mol Genet Metab Rep; 2018 Jun; 15():80-89. PubMed ID: 30009132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders.
    Rabbani B; Mahdieh N; Hosomichi K; Nakaoka H; Inoue I
    J Hum Genet; 2012 Oct; 57(10):621-32. PubMed ID: 22832387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exome sequencing greatly expedites the progressive research of Mendelian diseases.
    Zhang X
    Front Med; 2014 Mar; 8(1):42-57. PubMed ID: 24384736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exome Sequencing and the Management of Neurometabolic Disorders.
    Tarailo-Graovac M; Shyr C; Ross CJ; Horvath GA; Salvarinova R; Ye XC; Zhang LH; Bhavsar AP; Lee JJ; Drögemöller BI; Abdelsayed M; Alfadhel M; Armstrong L; Baumgartner MR; Burda P; Connolly MB; Cameron J; Demos M; Dewan T; Dionne J; Evans AM; Friedman JM; Garber I; Lewis S; Ling J; Mandal R; Mattman A; McKinnon M; Michoulas A; Metzger D; Ogunbayo OA; Rakic B; Rozmus J; Ruben P; Sayson B; Santra S; Schultz KR; Selby K; Shekel P; Sirrs S; Skrypnyk C; Superti-Furga A; Turvey SE; Van Allen MI; Wishart D; Wu J; Wu J; Zafeiriou D; Kluijtmans L; Wevers RA; Eydoux P; Lehman AM; Vallance H; Stockler-Ipsiroglu S; Sinclair G; Wasserman WW; van Karnebeek CD
    N Engl J Med; 2016 Jun; 374(23):2246-55. PubMed ID: 27276562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.
    Tetreault M; Bareke E; Nadaf J; Alirezaie N; Majewski J
    Expert Rev Mol Diagn; 2015 Jun; 15(6):749-60. PubMed ID: 25959410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Application of Whole Exome Sequencing to Identify Rare but Remediable Neurologic Disorders.
    Kim MJ; Yum MS; Seo GH; Lee Y; Jang HN; Ko TS; Lee BH
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33233562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concordance between whole-exome sequencing and clinical Sanger sequencing: implications for patient care.
    Hamilton A; Tétreault M; Dyment DA; Zou R; Kernohan K; Geraghty MT; ; ; Hartley T; Boycott KM
    Mol Genet Genomic Med; 2016 Sep; 4(5):504-12. PubMed ID: 27652278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exome sequencing in mostly consanguineous Arab families with neurologic disease provides a high potential molecular diagnosis rate.
    Charng WL; Karaca E; Coban Akdemir Z; Gambin T; Atik MM; Gu S; Posey JE; Jhangiani SN; Muzny DM; Doddapaneni H; Hu J; Boerwinkle E; Gibbs RA; Rosenfeld JA; Cui H; Xia F; Manickam K; Yang Y; Faqeih EA; Al Asmari A; Saleh MA; El-Hattab AW; Lupski JR
    BMC Med Genomics; 2016 Jul; 9(1):42. PubMed ID: 27435318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Application of Whole Exome Sequencing for Monogenic Disorders in PICU of China.
    Liu Y; Hao C; Li K; Hu X; Gao H; Zeng J; Guo R; Liu J; Guo J; Li Z; Qi Z; Jia X; Li W; Qian S
    Front Genet; 2021; 12():677699. PubMed ID: 34539730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders.
    Stark Z; Tan TY; Chong B; Brett GR; Yap P; Walsh M; Yeung A; Peters H; Mordaunt D; Cowie S; Amor DJ; Savarirayan R; McGillivray G; Downie L; Ekert PG; Theda C; James PA; Yaplito-Lee J; Ryan MM; Leventer RJ; Creed E; Macciocca I; Bell KM; Oshlack A; Sadedin S; Georgeson P; Anderson C; Thorne N; Melbourne Genomics Health Alliance ; Gaff C; White SM
    Genet Med; 2016 Nov; 18(11):1090-1096. PubMed ID: 26938784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances in Autism Spectrum Disorders: Applications of Whole Exome Sequencing Technology.
    Sener EF; Canatan H; Ozkul Y
    Psychiatry Investig; 2016 May; 13(3):255-64. PubMed ID: 27247591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
    Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
    BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Utility of Whole Exome Sequencing in Diagnosing Pediatric Neurological Disorders.
    Muthaffar OY
    Balkan J Med Genet; 2020 Nov; 23(2):17-24. PubMed ID: 33816068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.